Levosimendan vs dobutamine in septic shock

Journal of Critical Care

Volumn 24, Issue 3, 2009, Pages

  Alhashemi, Jamal A ^a   Alotaibi, Qamar A ^a   Abdullah, Ghadah M ^a   Shalabi, Sanaa A ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; LACTIC ACID; LEVOSIMENDAN; NORADRENALIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HUMAN; HYPOTENSION; LACTATE BLOOD LEVEL; OPEN STUDY; OXYGEN SATURATION; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK;

APACHE; CARDIOTONIC AGENTS; DOBUTAMINE; HUMANS; HYDRAZONES; LACTIC ACID; PYRIDAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK, SEPTIC;

EID: 67949092943     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.06.006     Document Type: Article

References (2)

1. Rivers E., et al. Early goal directed therapy for treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 368-1377
2. Kivikko, et al. Sustained hemodynamic effect of intravenous levosimendan. Circulation 107 (2003) 81-86